Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-29

Clinical Trial Update: NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing norepinephrine alone versus norepinephrine plus vasopressin for septic shock was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: University of Arkansas | Conditions: Shock, Septic | Phase 4 | Status: WITHDRAWN